Summary
Updated Aug 31, 2026
Stephen F. Betz is Chief Scientific Officer of Crinetics Pharmaceuticals, Inc. (CRNX). 3 SEC Form 4 filings on record going back to 2024, most recently on 18 March 2026. Most recent open-market trade: sold $160K of CRNX on 18 March 2026. Lifetime open-market sales: $397K.
Recent Transactions
4Every recent SEC Form 4 transaction Stephen F. Betz has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Stephen F. Betz go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. 2 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen F. Betz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeff E. Knight - $3.79M of CRNX open-market activity in the last 12 months
- Richard Scott Struthers - $1.00M of CRNX open-market activity in the last 12 months
- Dana Pizzuti - $808K of CRNX open-market activity in the last 12 months
- Matthew K. Fust - $716K of CRNX open-market activity in the last 12 months
- Stephanie Okey - $365K of CRNX open-market activity in the last 12 months
- Coelho Rogerio Vivaldi - $301K of CRNX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Stephen F. Betz?
Stephen F. Betz is a corporate insider, tracked as Chief Scientific Officer of Crinetics Pharmaceuticals, Inc. (CRNX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Stephen F. Betz last file a Form 4?
The most recent primary Form 4 on record is dated 18 March 2026, one of 3 filings going back to 2024.
Has Stephen F. Betz been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($397K) across all tracked filings.
Where can I see all of Stephen F. Betz's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Stephen F. Betz and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial